Ebola
Guinea declares Ebola epidemic following first deaths since 2016
Richard Staines
Ebola, infectious diseases, Merck & Co, vaccine
0 Comment
Regeneron’s antibody cocktail approved by FDA for Ebola
Richard Staines
COVID-19, Ebola, infectious diseases, Regeneron
0 Comment
Market Access/ News/ News/ Top stories
Regeneron’s Ebola drug heading for October verdict from FDA
Phil Taylor
antibody, Ebola, fda, infectious disease, Regeneron
0 Comment
Merck & Co in pole position for Ebola vaccine approval as FDA begins review
Richard Staines
Ebola, infectious diseases, Merck & Co
0 Comment
GSK exits Ebola vaccine R&D as J&J rival starts Uganda trial
Phil Taylor
Ebola, GlaxoSmithKline, infectious disease, Johnson & Johnson, vaccine
0 Comment